Comparison of relaxation induced by glyceryl trinitrate, isosorbide dinitrate, and sodium nitroprusside in bovine airways

The American Review of Respiratory Disease
C A GruetterM A Valentovic

Abstract

Nitrates are generally regarded as bronchial smooth muscle relaxants. However, reports about the clinical efficacy of the nitrates in the treatment of asthma are conflicting. In the present study, the relaxant effects of glyceryl trinitrate, isosorbide dinitrate, sodium nitroprusside, and isoproterenol were measured and compared in vitro in airway preparations isolated from variously sized airways in bovine lung. Strips of trachealis from cervical and thoracic ends of the trachea and rings of intrapulmonary bronchi of various diameters (14 to 1 mm outer diameters) were mounted for recording of isometric tension. Submaximal tone was induced using 10(-6) M carbachol, and responses to cumulatively increasing concentrations of glyceryl trinitrate, isosorbide dinitrate, sodium nitroprusside, or isoproterenol were measured. Isoproterenol (10(-8) to 10(-4) M) was equiactive as a relaxant in all preparations. Glyceryl trinitrate (10(-7) to 10(-5) M) relaxed trachealis, but was progressively and significantly less effective as a relaxant as the diameters of the bronchial rings decreased. Although less potent than isoproterenol, sodium nitroprusside (10(-6) to 10(-4) M) was effective in relaxing all the airway preparations. Similar to gl...Continue Reading

References

Jul 1, 1976·Journal of Applied Physiology·J H Fleisch, P J Calkins
Jul 1, 1976·Agents and Actions·G A Persson, M Ekman
Mar 1, 1984·Chest·J A Goldstein

❮ Previous
Next ❯

Citations

Apr 29, 1996·European Journal of Pharmacology·G Sadeghi-HashjinF P Nijkamp
Aug 1, 1996·Nuclear Medicine and Biology·T J McCarthyM J Welch
Mar 17, 1999·European Journal of Pharmacology·M de Oliveira EliasC Scavone
Sep 24, 2002·Pharmacology & Therapeutics·B J Nevin, K J Broadley
Apr 16, 1998·British Journal of Pharmacology·M HernándezU Simonsen
Jun 29, 1999·British Journal of Pharmacology·J HjobergG Hedenstierna
Oct 12, 1999·British Journal of Pharmacology·T L HwangC M Teng
Mar 1, 1995·Annals of Surgery·P C Kuo, R A Schroeder
May 23, 2008·Respirology : Official Journal of the Asian Pacific Society of Respirology·Mervat HallaniTerence C Amis
Jun 1, 1996·British Journal of Pharmacology·G Sadeghi-HashjinF P Nijkamp
Dec 1, 1996·The Journal of Pharmacy and Pharmacology·K VaaliH Vapaatalo
Jan 30, 2003·Thorax·F L M Ricciardolo
Oct 1, 1993·Thorax·P J Barnes, M G Belvisi
Aug 1, 1995·Thorax·A J Knox, A E Tattersfield
Nov 17, 1998·American Journal of Respiratory and Critical Care Medicine·P J Barnes
Aug 1, 1992·The Journal of Clinical Investigation·P M DupuyW M Zapol
Aug 1, 1996·Chest·T Mizutani, A J Layon
May 29, 2012·Pulmonary Pharmacology & Therapeutics·Charlotte K BillingtonSatoru Ito
Jun 1, 1992·Pulmonary Pharmacology·M A ValentovicC A Gruetter
Sep 11, 2002·Pulmonary Pharmacology & Therapeutics·L SpicuzzaG U Di Maria
Jul 23, 2004·Physiological Reviews·Fabio L M RicciardoloGert Folkerts
Oct 1, 1994·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·F P Nijkamp, G Folkerts
Jan 12, 2007·Cardiovascular Drug Reviews·Britt Elmedal LaursenUlf Simonsen
Apr 27, 2000·American Journal of Physiology. Lung Cellular and Molecular Physiology·X D LiuS I Rennard
Sep 25, 2017·Physiological Research·M AntosovaA Bencova

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.